Investigational Gene Therapy for Hereditary Angioedema Gets Orphan Drug Designation
qimono / Pixabay

Investigational Gene Therapy for Hereditary Angioedema Gets Orphan Drug Designation

According to a story from globnewswire.com, the gene therapy company Adverum Biotechnologies recently announced that the US Food and Drug Administration (FDA) has granted them Orphan Drug designation for their…

Continue Reading Investigational Gene Therapy for Hereditary Angioedema Gets Orphan Drug Designation
Hepatocellular Carcinoma Patient’s Twin Sister is Fundraising for £80,000 Treatment
nattanan23 / Pixabay

Hepatocellular Carcinoma Patient’s Twin Sister is Fundraising for £80,000 Treatment

According to a story from the St. Helens Star, Amanda Sackville-Wiggins was diagnosed with hepatocellular carcinoma, a rare type of liver cancer, just after her 21st birthday. The cancer was…

Continue Reading Hepatocellular Carcinoma Patient’s Twin Sister is Fundraising for £80,000 Treatment

A Man Who Set Up a Healthcare Company After Being Diagnosed with Neurofibromatosis Has Secured $3 Million Funding

  The healthcare technology company RDMD was founded by Onno Faber, who has himself been diagnosed with a rare disorder. RDMD, which describes itself as “dedicated to accelerating research” with…

Continue Reading A Man Who Set Up a Healthcare Company After Being Diagnosed with Neurofibromatosis Has Secured $3 Million Funding

A Treatment for Paroxysmal Nocturnal Hemoglobinuria Was Accepted for Priority Review

According to a story from Morningstar, the company Alexion Pharmaceuticals recently announced that the U.S. Food and Drug Administration (FDA) has agreed to review their Biologics Licensing Application for their…

Continue Reading A Treatment for Paroxysmal Nocturnal Hemoglobinuria Was Accepted for Priority Review
So Why DOES Canada have Scarcer Access to Rare Disease Therapies?
FrankWinkler / Pixabay

So Why DOES Canada have Scarcer Access to Rare Disease Therapies?

According to a story from CheckOrphan, Durhane Wong-Rieger, the CEO of the Canadian Organization for Rare Disorders, says that the Canadian health system has been letting down the roughly three…

Continue Reading So Why DOES Canada have Scarcer Access to Rare Disease Therapies?